Podstawowe statystyki
| CIK | 1522704 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medifirst Solutions Inc
SEC Filings (Chronological Order)
Na tej stronie znajduje się pełna, chronologiczna lista zgłoszeń SEC, z wyłączeniem zgłoszeń własności, które udostępniamy gdzie indziej.
| May 2, 2022 | ||
| July 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2021 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction of incorporation) (Commission F |
|
| July 26, 2021 |
Exhibit 17.1 4400 U.S. 9 South, Suite 1000, Freehold NJ 07728 Public Trading Company since 2011 July 23, 2021 Letter of Resignation This letter confirms, that I, Thomas Griffin, resign immediately as CEO and sole Director of Medifirst Solutions, Inc., a New Jersey based Nevada Corporation. Sincerely, /s/ Thomas Griffin July 23, 2021 Name: Thomas Griffin Date CEO |
|
| July 7, 2021 |
Exhibit 10.1 SHEFFORD CAPITAL MANAGEMENT, LLC. Medifirst Solutions, Inc. ENGAGEMENT AGREEMENT THIS ENGAGEMENT AGREEMENT, (the ?Agreement?) dated as of the date written, is by and between Shefford Capital Management, LLC. (the ?Advisor?) and Medifirst Solutions, Inc. (the ?Company?). WHEREAS, the Company desires to retain the Advisor and the Advisor desires to be retained by the Company pursuant to |
|
| July 7, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 ea143860-8kmedifirst.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2021 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other |
|
| June 24, 2021 |
Letter of Resignation from Bruce Schoengood Exhibit 17.1 6/23/21 Letter of resignation, This letter confirms, that I, Bruce Schoengood resign immediately as President and sole Director of Medifirst Solutions, Inc., a Nevada Company based in New Jersey. Sincerely, /s/ Bruce Schoengood Bruce Schoengood President |
|
| June 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2021 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction of incorporation) (Commission F |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| May 15, 2020 |
8-K 1 ea121837medifirst8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2020 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction (Commi |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 30, 2020 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No. |
|
| November 19, 2019 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDI |
|
| November 15, 2019 |
MFST / Medifirst Solutions Inc. NT 10-Q - - NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| October 25, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 16, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, N |
|
| October 25, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 24, 2019 (October 18, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No. |
|
| October 25, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 29, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 21, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY |
|
| August 29, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 29, 2019 |
Exhibit 99.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 28, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY |
|
| August 29, 2019 |
Exhibit 99.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 29, 2019 |
8-K 1 f8k082319medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 29, 2019 (August 23, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27 |
|
| August 19, 2019 |
MFST / Medifirst Solutions Inc. 10-Q - Quarterly Report - QUARTELY REPORT 10-Q 1 f10q0619medifirstsolutions.htm QUARTELY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition peri |
|
| August 15, 2019 |
MFST / Medifirst Solutions Inc. NT 10-Q - - NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on F |
|
| June 18, 2019 |
8-K 1 f8k061419medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 18, 2019 (June 14, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-388 |
|
| June 18, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 11, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 1 |
|
| June 18, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| May 20, 2019 |
MFST / Medifirst Solutions Inc. 10-Q - Quarterly Report - QUARTERLY REPORT 10-Q 1 f10q0319medifirst.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| May 15, 2019 |
MFST / Medifirst Solutions Inc. NT 10-Q NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on |
|
| May 2, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 26, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY |
|
| May 2, 2019 |
8-K 1 f8k042619medifirstsolu.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2019 (April 26, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 ( |
|
| May 2, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| May 2, 2019 |
MFST / Medifirst Solutions Inc. / BESSER JAMES E Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 15, 2019 |
Exhibit 21.1 List of Subsidiaries Name of Subsidiaries Percentage Owned Jurisdiction Medical Lasers Manufacturer, Inc. 100% Nevada Concierge Concepts Rx Inc. 100% New Jersey USA Pharma Corporation 51% New Jersey |
|
| April 15, 2019 |
MFST / Medifirst Solutions Inc. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 000-55465 Medifirst Solutions, |
|
| April 1, 2019 |
MFST / Medifirst Solutions Inc. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| March 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 29, 2019 (March 26, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| March 29, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| March 29, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 22, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY |
|
| March 8, 2019 |
8-K 1 f8k030819medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 8, 2019 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or o |
|
| February 27, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as February 20, 2019, by and between MediFirst Solutions, Inc. , a Nevada corporation, with headquarters located at 4400 Route 9 South, Suite 1000, Freehold, New Jersey (the “Company”) and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”). |
|
| February 27, 2019 |
Exhibit 99.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| February 27, 2019 |
Exhibit 99.6 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| February 27, 2019 |
MediFirst Solutions, Inc. 8% CONVERTIBLE REDEEMABLE NOTE DUE August 20, 2020 Exhibit 99.2 THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”) US $54,00 |
|
| February 27, 2019 |
Exhibit 99.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 25, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and Bellridge Capital, LP., a Delaware Corporation, with its address at 515 E. Las Olas Boulevard, Suite 120A, Fort Laude |
|
| February 27, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2019 (February 21, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| February 27, 2019 |
Exhibit 99.5 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 27, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with headquarters located at 4400 Route 9 South, Suite 1000, Freehold, NJ 07728 (the “Company”), and CROWN BRIDGE PARTNERS, LLC, a New York limited liability company, with its address at 1173a 2nd Avenue, Sui |
|
| February 12, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 4, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, N |
|
| February 12, 2019 |
8-K 1 f8k020619medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 6, 2019 (February 12, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 |
|
| February 12, 2019 |
Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| February 5, 2019 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 24, 2019, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, N |
|
| February 5, 2019 |
EX-99.2 3 f8k012819ex99-2medifirst.htm 8% CONVERTIBLE PROMISSORY NOTE DUE MAY 24, 2020 Exhibit 99.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRA |
|
| February 5, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 5, 2019 (January 28, 2019) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| January 11, 2019 |
MFST / Medifirst Solutions Inc. REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medifirst Solutions, Inc. (Exact name of issuer as specified in its charter) NEVADA 23-3888260 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Route 9 South. Suite 1000 Freehold, NJ 07728 (Address of Princi |
|
| January 11, 2019 |
Medifirst Solutions, Inc. 2019 Equity Incentive Plan Exhibit 4.1 Medifirst Solutions, Inc. 2019 EQUITY INCENTIVE PLAN This Medifirst Solutions, Inc. 2019 EQUITY Incentive Plan (the “Plan”) is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Parti |
|
| November 28, 2018 |
MEDIFIRST SOLUTIONS FINALIZES RELATIONSHIP WITH EX-99.2 3 f8k112118ex99-2medifirst.htm PRESS RELEASE DATED NOVEMBER 28, 2018 Exhibit 99.2 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS FINALIZES RELATIONSHIP WITH DR. GUPTA PHARMA Freehold, NJ – November 28, 2018 – MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst |
|
| November 28, 2018 |
Exhibit 99.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| November 28, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 28, 2018 (November 21, 2018) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| November 21, 2018 |
MEDIFIRST SOLUTIONS ANNOUNCES NEW AGREEMENT FOR CBD PRODUCTS AND DISTRIBUTION Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS ANNOUNCES NEW AGREEMENT FOR CBD PRODUCTS AND DISTRIBUTION Freehold, NJ – November 21, 2018 – MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k |
|
| November 21, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 21, 2018 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| November 19, 2018 |
MFST / Medifirst Solutions Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDI |
|
| November 15, 2018 |
MFST / Medifirst Solutions Inc. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| October 12, 2018 |
Exhibit 99.1 CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES OF SERIES C CONVERTIBLE PREFERRED STOCK MEDIFIRST SOLUTIONS, INC. WHEREAS, the Articles of Incorporation of the Corporation provide for a class of shares known as Preferred Stock, issuable from time to time; WHEREAS, the Board of Directors of the Corporation is authorized to determine or alter the rights, preferences, pr |
|
| October 12, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 12, 2018 (October 5, 2018) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| October 12, 2018 |
Exhibit 99.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 5, 2018, by and between MEDIFIRST SOLUTIONS, INC., a Nevada corporation, with its address at 4400 Route 9 South, Suite 1000, Freehold NJ 07728 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY |
|
| October 12, 2018 |
Exhibit 99.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 20, 2018 |
MFST / Medifirst Solutions Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRST |
|
| August 15, 2018 |
MFST / Medifirst Solutions Inc. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on F |
|
| July 25, 2018 |
MEDIFIRST SOLUTIONS ANNOUNCES COMPANY UPDATE Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS ANNOUNCES COMPANY UPDATE Freehold, NJ – July 25, 2018 – MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and management consulting s |
|
| July 25, 2018 |
8-K 1 f8k072318medifirstsolution.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2018 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 333-178825 27-3888260 State or |
|
| May 21, 2018 |
MFST / Medifirst Solutions Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRS |
|
| May 16, 2018 |
MFST / Medifirst Solutions Inc. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on |
|
| May 14, 2018 |
MEDIFIRST SOLUTIONS TO UPDATE SHAREHOLDERS Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS TO UPDATE SHAREHOLDERS Freehold, NJ – May 14, 2018 – MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-810 |
|
| May 14, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2018 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| April 12, 2018 |
MFST / Medifirst Solutions Inc. ANNUAL REPORT (Annual Report) 10-K 1 f10k2017medifirstsolutions.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Co |
|
| April 3, 2018 |
MFST / Medifirst Solutions Inc. NOTIFICATINO OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2017 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| January 26, 2018 |
MFST / Medifirst Solutions Inc. REGISTRATION STATEMENT S-8 1 fs82018medifirstsolutions.htm REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medifirst Solutions, Inc. (Exact name of issuer as specified in its charter) NEVADA 23-3888260 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Rout |
|
| January 26, 2018 |
Medifirst Solutions, Inc. 2018 Equity Incentive Plan(12) EX-4.8 2 fs82018ex4-8medifirst.htm MEDIFIRST SOLUTIONS, INC. 2018 EQUITY INCENTIVE PLAN Exhibit 4.8 Medifirst Solutions, Inc. 2018 EQUITY INCENTIVE PLAN This Medifirst Solutions, Inc. 2018 EQUITY Incentive Plan (the “Plan”) is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are |
|
| January 25, 2018 |
Mail Stop 3030 January 25, 2018 Via E-mail Bruce Schoengood Chief Executive Officer Medifirst Solutions, Inc. |
|
| January 24, 2018 |
MFST / Medifirst Solutions Inc. AMENDMENT NO. 1 TO FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 000-55465 Med |
|
| January 17, 2018 |
MFST / Medifirst Solutions Inc. ESP 4400 U.S. 9 South, Suite 1000, Freehold NJ 07728 January 17, 2018 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Kevin J. Kuhar, Gary Newberry and Martin James Re: Medifirst Solutions, Inc. Form 10-K for the Fiscal Year Ended December 31, 2016 Filed April 6, 2017 File No. 0-55465 Ladies and Gentlemen: Please find |
|
| December 19, 2017 |
Mail Stop 3030 December 19, 2017 Via E-mail Bruce Schoengood Chief Executive Officer Medifirst Solutions, Inc. |
|
| December 18, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 f8k121417medifirstsolution.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 15, 2017 (December 14, 2017) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 |
|
| December 18, 2017 |
MEDIFIRST SOLUTIONS ANNOUNCES AGREEMENT WITH LIFE SCIENCE QUEST EX-99.1 2 f8k121417ex99-1medifirst.htm PRESS RELEASE DATED DECEMBER 14, 2017 Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS ANNOUNCES AGREEMENT WITH LIFE SCIENCE QUEST Freehold, NJ – December 14, 2017 – MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst” |
|
| December 18, 2017 |
MEDIFIRST SOLUTIONS ANNOUNCES SHAREHOLDER UPDATE Exhibit 99.2 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS ANNOUNCES SHAREHOLDER UPDATE Freehold, NJ ? December 8, 2017 ? MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the ?Company? or ?Medifirst?), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machin |
|
| November 20, 2017 |
MFST / Medifirst Solutions Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDI |
|
| November 15, 2017 |
MFST / Medifirst Solutions Inc. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report |
|
| September 25, 2017 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8-K 1 f8k092517medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 25, 2017 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 333-178825 27-3888260 Stat |
|
| September 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 31, 2017 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| September 6, 2017 |
MEDIFIRST SIGNS DISTRIBUTION AGREEMENT FOR MOROCCO Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SIGNS DISTRIBUTION AGREEMENT FOR MOROCCO Freehold, NJ ? August 31, 2017 ? MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the ?Company? or ?Medifirst?), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machi |
|
| September 6, 2017 |
Exhibit 99.1 Dated 8/31/17 MEDICAL LASERS MANUFACTURER, INC., a Nevada corporation, with offices located at 4400 Route 9 South, Suite 1000, Freehold, New Jersey 07728 - and - INTER EQUIPEMENT MEDICAL SERVICES MAROC 8, Rue Ezzahraoui A.Kacem. Quartier des H?pitaux 20360 Casablanca, MOROCCO MASTER EXCLUSIVE DISTRIBUTION AGREEMENT 1 CONTENTS Clause Page 1 DEFINITIONS AND INTERPRETATION 3 2 APPOINTMEN |
|
| September 1, 2017 |
Medifirst Solutions DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(C) of the SECURITIES EXCHANGE ACT OF 1934 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter.) NEVADA (State or other jurisdiction of incorporation or organization.) 58471B 103 23-3888260 (CUSIP Number) (IRS Employer Identification Number) 4 |
|
| August 21, 2017 |
MFST / Medifirst Solutions Inc. QUARTERLY REPORT (Quarterly Report) 10-Q 1 f10q0617medifirstsolutions.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition per |
|
| August 18, 2017 |
Medifirst Solutions PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Information Statement ? Definitive Information Statement ? Confidential, for use of the Commis |
|
| August 15, 2017 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on F |
|
| August 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2017 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| August 7, 2017 |
Exhibit 99.1 Dated 8/4/17 MEDICAL LASERS MANUFACTURER, INC., a Nevada corporation, with offices located at 4400 Route 9 South, Suite 1000, Freehold, New Jersey 07728 - and ? AOTEX (O.S.) S.A.L. MASTER EXCLUSIVE DISTRIBUTION AGREEMENT BEY1707-1001 MASTER EXCLUSIVE DISTRIBUTION AGREEMENT 1 CONTENTS Clause Page 1 DEFINITIONS AND INTERPRETATION 3 2 APPOINTMENT OF DISTRIBUTOR 6 3 CONSIDERATION 7 4 PROD |
|
| August 7, 2017 |
MEDIFIRST SIGNS DISTRIBUTION AGREEMENT Exhibit 99.2 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SIGNS DISTRIBUTION AGREEMENT Freehold, NJ ? August 4, 2017 ? MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the ?Company? or ?Medifirst?), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-81020 |
|
| July 20, 2017 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS signs PROFESSIONAL FOOTBALL PLAYER, Jordan Poyer, as spokesperson for the Time Machine Laser Freehold, NJ ? July 18, 2017 ? MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the ?Company? or ?Medifirst?), a provider of innovative lase |
|
| July 20, 2017 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 20, 2017 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| July 17, 2017 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 17, 2017 (July 14, 2017) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| July 17, 2017 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com Freehold NJ ? July 14, 2017 ? MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the ?Company? or ?Medifirst?) would like to update shareholders in a Q&A format regarding the status of current sales and operations in connection with its FDA-cleared Infrar |
|
| June 20, 2017 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 20, 2017 (June 16, 2017) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| May 22, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRS |
|
| May 16, 2017 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on |
|
| May 8, 2017 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of May 1, 2017, by and between MEDIFIRST SOLUTIONS, Inc., a Nevada corporation, with headquarters located at 4400 Route 9 South, Suite 1000, Freehold, NJ 07728 (the ?Company?), and LG CAPITAL FUNDING, LLC, a New York limited liability company, with its address at 1218 Union Street, Suite #2, B |
|
| May 8, 2017 |
MEDIFIRST SOLUTIONS, INC. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 1, 2018 BACK END NOTE Exhibit 99.3 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $131,250.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTI |
|
| May 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2017 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| May 8, 2017 |
MEDIFIRST SOLUTIONS, INC. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 1, 2018 Exhibit 99.2 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE ?1933 ACT) US $131,250.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTI |
|
| May 4, 2017 |
Medifirst Solutions, Inc. 2017 Equity Incentive Plan(11) Exhibit 4.8 Medifirst Solutions, Inc. 2017 EQUITY INCENTIVE PLAN This Medifirst Solutions, Inc. 2017 EQUITY Incentive Plan (the "Plan") is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Parti |
|
| May 4, 2017 |
Medifirst Solutions REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medifirst Solutions, Inc. (Exact name of issuer as specified in its charter) NEVADA 23-3888260 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Route 9 South. Suite 1000 Freehold, NJ 07728 (Address of Princi |
|
| April 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 000-55465 Medifirst Solutions, |
|
| April 3, 2017 |
Medifirst Solutions NOTIFICATION OF LATE FILING NT 10-K 1 extf10k2016medifirst.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on |
|
| February 2, 2017 |
MFST / Medifirst Solutions Inc. / SBI INVESTMENTS LLC 2014-1 - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Medifirst Solutions Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58471B103 (CUSIP Number) January 24, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| January 27, 2017 |
MFST / Medifirst Solutions Inc. / LG CAPITAL FUNDING, LLC - SCHEDULE 13G Passive Investment SC 13G 1 f13g012717sc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Medifirst Solutions Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58471B103 (CUSIP Number) January 23, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| January 19, 2017 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 17, 2017 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| January 19, 2017 |
Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai Exhibit 99.1 Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai FREEHOLD, NJ - (Marketwired) - 01/17/17 - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding its previous announcement about international sales for its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. Medifirst is p |
|
| December 8, 2016 |
Medifirst Solutions, Inc. MFST Equity Incentive Plan(10) Exhibit 4.8 Medifirst Solutions, Inc. MFST EQUITY INCENTIVE PLAN This Medifirst Solutions, Inc. MFST Equity Incentive Plan (the "Plan") is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Parti |
|
| December 8, 2016 |
Medifirst Solutions REGISTRATION STATEMENT S-8 1 fs82016medifirstsolutions.htm REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medifirst Solutions, Inc. (Exact name of issuer as specified in its charter) NEVADA 23-3888260 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Rout |
|
| November 15, 2016 |
Medifirst Solutions NOTIFICATION OF LATE FILING SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-55465 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form 20-F ☐ Transition Report on Form N-SAR For the Transition Period Ended: Noth |
|
| November 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDI |
|
| October 19, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 17, 2016 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| October 19, 2016 |
Medifirst Solutions Announces Update Regarding Sales and Operations Exhibit 99.1 Medifirst Solutions Announces Update Regarding Sales and Operations FREEHOLD, NJ?(Marketwired - Oct 17, 2016) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding recent company developments regarding its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. Medifirst is pleased to announce that |
|
| October 17, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 11, 2016 MEDIFIRST SOLUTIONS, INC. |
|
| October 17, 2016 |
Convertible Redeemable Replacement Note due March 27, 2018(9) Exhibit 10.2 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?) OR ANY STATE SECURITIES LAWS AND NEITHER THIS NOTE NOR ANY INTEREST THEREIN NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| October 17, 2016 |
Convertible Redeemable Note due March 27, 2018(9) Exhibit 10.1 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?) OR ANY STATE SECURITIES LAWS AND NEITHER THIS NOTE NOR ANY INTEREST THEREIN NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| August 15, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 11, 2016 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| August 15, 2016 |
Medifirst Solutions Appoints Richard J. Berman to Its Advisory Board Exhibit 99.1 Medifirst Solutions Appoints Richard J. Berman to Its Advisory Board FREEHOLD, NJ-(Marketwired - Aug 11, 2016) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology that recently received FDA 510(k) clearance to market its Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce the appoin |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRST |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRST |
|
| August 2, 2016 |
Medifirst Solutions, Inc. 2016 Equity Incentive Plan(8) Exhibit 4.8 Medifirst Solutions, Inc. 2016 EQUITY INCENTIVE PLAN This Medifirst Solutions, Inc. 2016 Equity Incentive Plan (the "Plan") is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Parti |
|
| August 2, 2016 |
Medifirst Solutions REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medifirst Solutions, Inc. (Exact name of issuer as specified in its charter) NEVADA 23-3888260 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Route 9 South. Suite 1000 Freehold, NJ 07728 (Address of Princi |
|
| July 19, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 18, 2016 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| July 19, 2016 |
Medifirst Solutions Sets Pricing for Its Flagship Product Exhibit 99.1 Medifirst Solutions Sets Pricing for Its Flagship Product FREEHOLD, NJ-(Marketwired - July 18, 2016) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the ?Company? or ?Medifirst?) would like to continue to update shareholders regarding its flagship product, the infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. As recently announced, the Company, in response to its Prem |
|
| July 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 14, 2016 (July 8, 2016) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| June 17, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2016 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-3888260 (State or other jurisdiction (Commission File Number) (IRS Employer incorporation) Identification No. |
|
| June 17, 2016 |
Medifirst Solutions Announces Successful Completion of Testing for the Time Machine Laser Series EX-99.1 2 f8k061616ex99imedifirst.htm PRESS RELEASE DATED JUNE 16, 2016 Exhibit 99.1 Medifirst Solutions Announces Successful Completion of Testing for the Time Machine Laser Series FREEHOLD, NJ-(Marketwired - June 16, 2016) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders on its status regarding its FDA 510(k) submission for The Time Machi |
|
| May 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55465 MEDIFIRS |
|
| May 17, 2016 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended March 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Fo |
|
| May 6, 2016 |
8% Convertible Redeemable Note due May 2, 2017(7) Exhibit 10.2 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $57,750.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTIB |
|
| May 6, 2016 |
8% Convertible Redeemable Replacement Note due May 2, 2017(7) Exhibit 10.3 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $60,000.00 PARTIAL REPLACEMENT NOTE- ORIGINALLY I |
|
| May 6, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 6, 2016 (May 2, 2016) MEDIFIRST SOLUTIONS, INC. |
|
| May 6, 2016 |
Securities Purchase Agreement, dated May 2, 2016(7) Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of May 2, 2016, by and between MEDIFIRST SOLUTIONS, Inc., a Nevada corporation, with headquarters located at 4400 Route 9 South, Suite 1000, Freehold, NJ 07728 (the ?Company?), and SEA OTTER GLOBAL VENTURES, LLC, with its address at 369 Lexington Avenue, 2nd Floor, NY, NY 10017 (the ?Buyer?). |
|
| April 14, 2016 |
Employment Agreement between the Company and Bruce Schoengood(6) Exhibit 10.13 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is executed on March 18, 2016 to be effective as of January 1, 2012 between Medifirst Solutions, Inc., a Nevada corporation, (?Company?) and Bruce Schoengood (?Employee?). Recital The Company desires to employ Employee as President and Chief Executive Officer of the Company and Employee desires to accept such employment on |
|
| April 14, 2016 |
Trademark Purchase Agreement, dated August 21, 2015(6) Exhibit 10.4 TRADEMARK ASSIGNMENT AGREEMENT This Trademark Assignment Agreement (?Agreement?) is entered into as of August 21, 2015 (?Effective Date?) b by and between Bradley Schoengood (?Assignor?) and Medical Lasers Manufacturer, Inc., a Nevada corporation (?Assignee?). WHEREAS, the Assignor owns the entire right, title and interest in and to certain U.S. trademark registered with the United St |
|
| April 14, 2016 |
Certificate of Amendment to Articles of Incorporation filed on November 19, 2015(6) Exhibit 3.5 From: 503 227 2980 Received by: NV Secretary of State BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov Filed in the office of Document Number /s/ Barbara K. Cegavske 20150506371-30 Barbara K. Cegavske Filing Date and Time Secretary of State 11/19/2015 12:02 PM State of Nevada Entity Number E0536112010-6 |
|
| April 14, 2016 |
Amended Certificate of Designation of Series A Preferred Stock filed on October 15, 2015(6) Exhibit 3.7 BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov Filed in the office of Document Number /s/ Barbara K. Cegavske 20150456146-34 Barbara K. Cegavske Filing Date and Time Secretary of State 10/15/2015 2:12 PM State of Nevada Entity Number E0536112010-6 Amendment to Certificate of Designation After Issuance |
|
| April 14, 2016 |
Convertible Debenture, dated June 12, 2015(6) Exhibit 4.2 MEDIFIRST SOLUTIONS CONVERTIBLE DEBENTURE THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SUCH LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS OF TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD |
|
| April 14, 2016 |
8% Convertible Redeemable Back End Note due March 7, 2017(6) Exhibit 10.10 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $46,803.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTI |
|
| April 14, 2016 |
8% Convertible Redeemable Replacement Note due February 28, 2017(6) Exhibit 10.11 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $39,557.48 REPLACEMENT NOTE ORIGINALLY ISSUED AU |
|
| April 14, 2016 |
8% Convertible Redeemable Note due October 8, 2016(6) Exhibit 4.3 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $31,000.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTIBL |
|
| April 14, 2016 |
5% Convertible Promissory Note due October 12, 2016(6) Exhibit 4.4 NEITHER THE ISSUANCE OR SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGITERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURI |
|
| April 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2015 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 000-55465 Medifirst Solutions, |
|
| April 14, 2016 |
Sale and Purchase Agreement for Goods, dated August 25, 2015(6) Exhibit 10.3 Sale and Purchase Agreement for Goods Dated: August 25, 2015 Between: Bradley Schoengood 1015 Spanish River Road Boca Raton, FL 33432 (?Seller?) And: Medical Lasers Manufacturer, Inc. 4400 Route 9 South, Suite 1000 Freehold, NY 07726 (?Buyer?) 1. Buyer hereby purchases from Seller and Seller hereby sells to Buyer hand-held laser devices (collectively referred to as the ?Units?), speci |
|
| April 14, 2016 |
8% Convertible Redeemable Note due March 7, 2017(6) EX-10.9 9 f10k2015ex10ixmedifirst.htm 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 7, 2017 Exhibit 10.9 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROM |
|
| March 31, 2016 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended December 31, 2015 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on |
|
| March 14, 2016 |
Product and Know-How License Agreement(3) Exhibit 10.1 Product and Know-How License Agreement This Product and Know-How License Agreement ("Agreement"), entered into as of this 8th day of March, 2016 and made effective as of October 1, 2015 (the "Effective Date"), is by and between Medical Lasers Manufacturer, Inc., a Florida corporation doing business as Laser Lab Corp., with offices located at 101 Spanish River Road, 305, Boca Raton, Fl |
|
| March 14, 2016 |
Promissory Note, dated March 8, 2016(3) Exhibit 4.1 PROMISSORY NOTE $150,000.00 March 8, 2016 The undersigned, Medifirst Solutions, Inc., a Nevada corporation, ("Maker") promises to pay to the order of Medical Lasers Manufacturer, Inc., a Florida corporation doing business as Laser Lab Corp., with offices located at 101 Spanish River Road, 305, Boca Raton, Florida 33432 ("Holder") the principal sum of ONE HUNDRED FIFTY THOUSAND DOLLARS |
|
| March 14, 2016 |
Certificate of Designation of Series B Convertible Preferred Stock filed on September 24, 2015(3) Exhibit 3.1 exhibit a CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES OF SERIES B CONVERTIBLE PREFERRED STOCK MEDIFIRST SOLUTIONS, INC. WHEREAS, the Articles of Incorporation of the Corporation provide for a class of shares known as Preferred Stock, issuable from time to time; WHEREAS, the Board of Directors of the Corporation is authorized to determine or alter the rights, prefer |
|
| March 14, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 14, 2016 (March 8, 2016) MEDIFIRST SOLUTIONS, INC. |
|
| March 10, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 f8k031016medifirstsolutions.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 10, 2016 (March 8, 2016) MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 000-55465 27-38 |
|
| March 10, 2016 |
MEDIFIRST SOLUTIONS ANNOUNCES EXPANSION TO THE TIME MACHINE LASER SERIES EX-99.1 2 f8k031016ex99imedifirstsolu.htm PRESS RELEASE DATED MARCH 10, 2016 Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS ANNOUNCES EXPANSION TO THE TIME MACHINE LASER SERIES Freehold, NJ – March 8, 2016 – MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the “company” or “Medi |
|
| March 4, 2016 |
MFST / Medifirst Solutions Inc. / VIS VIRES GROUP, INC. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1)* MEDIFIRST SOLUTIONS, INC. (Name of issuer) Common Stock, $0.0001 value per share (Title of class of securities) 58471B103 (CUSIP number) February 29, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 12, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 11, 2016 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 333-178825 27-3888260 (State or other (Commission File Number) (IRS Employer jurisdiction incorporation) Identification No. |
|
| February 12, 2016 |
MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE ON FDA SUBMISSION Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE ON FDA SUBMISSION Freehold, NJ ? February 11, 2016 ? MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the ?company? or ?Medifirst?) would like to update shareholders on the progress of its 510(k) submission to |
|
| February 5, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 5, 2016 MEDIFIRST SOLUTIONS, INC. |
|
| January 14, 2016 |
8% Convertible Redeemable Note due January 7, 2017(5) EX-10.2 3 f8k010716ex10iimedifirstsol.htm 8% CONVERTIBLE REDEEMABLE NOTE DUE JANUARY 7, 2017 Exhibit 10.2 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATION |
|
| January 14, 2016 |
8% Convertible Redeemable Replacement Note due January 7, 2017(5) EX-10.4 5 f8k010716ex10ivmedifirst.htm 8% CONVERTIBLE REDEEMABLE REPLACEMENT NOTE DUE JANUARY 7, 2017 Exhibit 10.4 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND R |
|
| January 14, 2016 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2016 MEDIFIRST SOLUTIONS, INC. |
|
| January 14, 2016 |
8% Convertible Redeemable Back End Note due January 7, 2017(5) Exhibit 10.3 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT) US $50,000.00 MEDIFIRST SOLUTIONS, INC. 8% CONVERTIB |
|
| January 14, 2016 |
Securities Purchase Agreement, dated January 7, 2016(5) EX-10.1 2 f8k010716ex10imedifirstsol.htm SECURITIES PURCHASE AGREEMENT, DATED JANUARY 7, 2016 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 7, 2016, by and between MEDIFIRST SOLUTIONS, Inc., a Nevada corporation, with headquarters located at 4400 Route 9 South, Suite 1000, Freehold, NJ 07728 (the “Company”), and LG CAPITAL FUND |
|
| December 31, 2015 |
ANTON & CHIA, LLP 3027 Townsgate Rd., Ste. 130 Westlake Village, CA 91361 December 30, 2015 Exhibit 16.1 ANTON & CHIA, LLP 3027 Townsgate Rd., Ste. 130 Westlake Village, CA 91361 December 30, 2015 United States Securities & Exchange Commission 100 F Street, NE Washington, D.C.20549 Ladies & Gentlemen: We have read the disclosures on the Form 8K report of Medifirst Solutions, Inc. dated December 30, 2015 and we are in agreement with the statements contained therein, as they pertain to our |
|
| December 31, 2015 |
8-K 1 f8k123015medifirstsolut.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 10, 2015 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 333-178825 27-3888260 State or |
|
| November 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MED |
|
| November 23, 2015 |
David A. Aronson, CPA, P.A. 1000 NE 176th Street North Miami Beach, FL 33162 June 25, 2015 Exhibit 16.1 David A. Aronson, CPA, P.A. 1000 NE 176th Street North Miami Beach, FL 33162 June 25, 2015 United States Securities & Exchange Commission 100 F Street, NE Washington, D.C.20549 Ladies & Gentlemen: We have read the disclosures on the Form 8K report of Medifirst Solutions, Inc. dated June 25, 2015 and we are in agreement with the statements contained therein, as they pertain to our enga |
|
| November 23, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 19, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| November 18, 2015 |
Medifirst Solutions DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2) ? Definitive Information Statement MEDIFIRST SOLUTIONS, INC. (Name of Re |
|
| November 17, 2015 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report |
|
| November 9, 2015 |
MFST / Medifirst Solutions Inc. / VIS VIRES GROUP, INC. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. )* MEDIFIRST SOLUTIONS, INC. (Name of issuer) Common Stock, $0.0001 value per share (Title of class of securities) 58471B103 (CUSIP number) November 9, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| October 30, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 27, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| October 19, 2015 |
Medifirst Solutions SCHEDULE 14C INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(C) of the SECURITIES EXCHANGE ACT OF 1934 MEDIFIRST SOLUTIONS, INC. (Exact name of registrant as specified in its charter.) NEVADA (State or other jurisdiction of incorporation or organization.) 58471B 103 23-3888260 (CUSIP Number) (IRS Employer Identification Number) 4 |
|
| October 16, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 12, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| September 11, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| September 9, 2015 |
September 9, 2015 Bruce Schoengood Chief Executive Officer Medifirst Solutions, Inc. |
|
| September 8, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 333-178825 Medifirst Solutions |
|
| August 31, 2015 |
MEDIFIRST SOLUTIONS, INC. 4400 Route 9 South, Suite 1000 Freehold, NJ 07728 August 31, 2015 Lyn Shenk Branch Chief Office of Transportation and Leisure United States Securities and Exchange Commission Washington, D.C. 20549 Medifirst Solutions, Inc. Form 10-K for Fiscal Year Ended December 31, 2014 Filed April 15, 2015 File No.000-55465 Dear Mr. Shenk, We are responding to your comment letter of A |
|
| August 25, 2015 |
Mail Stop 3561 August 25, 2015 Bruce Schoengood Chief Executive Officer Medifirst Solutions, Inc. |
|
| August 21, 2015 |
Medifirst Solutions FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 19, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| August 21, 2015 |
Agreement and Plan of Reorganization, dated August 19, 2015(4) Exhibit 10.1 AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (?Agreement?) is dated as of August 19, 2015, and is by and among Medifirst Solutions, Inc., a Nevada corporation (?Medifirst?)? Medical Lasers Manufacturer, Inc., a Nevada corporation (?MLM?) and Bruce Schoengood (?Schoengood?). R E C I T A L S WHEREAS, Schoengood is the holder of 20,000 shares of the comm |
|
| August 19, 2015 |
MFST / Medifirst Solutions Inc. / NADLAN INC. - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Medifirst Solutions, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58471B103 (CUSIP Number) August 19, 2015 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| August 18, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIRS |
|
| August 14, 2015 |
Medifirst Solutions NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended June 30, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on For |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 11, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| July 9, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 8, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| July 8, 2015 |
Medifirst Solutions FORM 8-A12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Medifirst Solutions, Inc. (Exact name of registrant as specified in its charter) Nevada 27-3888260 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No. |
|
| June 25, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 22, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| June 25, 2015 |
David A. Aronson, CPA, P.A. 1000 NE 176th Street North Miami Beach, FL 33162 June 25, 2015 Exhibit 16.1 Exhibit 16.1 Letter from David A. Aronson, CPA, P.A., pursuant to Item 304 of Regulation S-K David A. Aronson, CPA, P.A. 1000 NE 176th Street North Miami Beach, FL 33162 June 25, 2015 United States Securities & Exchange Commission 100 F Street, NE Washington, D.C.20549 Ladies & Gentlemen: We have read the disclosures on the Form 8K report of Medifirst Solutions, Inc. dated June 25, 20 |
|
| June 18, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 12, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| May 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIR |
|
| May 18, 2015 |
Medifirst Solutions NOTIFICATION OF LATE FILING NT 10-Q 1 extf10q0315medifirst.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended March 31, 2015 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form |
|
| April 22, 2015 |
EXHIBIT 10.1 AGREEMENT Effective Date: April 14, 2015 By: Medifirst Solutions, Inc. (?Medifirst?) And: Dr. Park Avenue Inc. (?Dr. Park Ave.?) And: Paul Fondacaro M.D. (?Fondacaro?) And: Bruce Schoengood (?Schoengood?) Collectively, the foregoing shall be referred to as the ? Parties?. WHEREAS, Dr. Park Ave. is the wholly-owned subsidiary of Medifirst; and WHEREAS, Fondacaro is the President and a |
|
| April 22, 2015 |
Medifirst Solutions CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 14, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| April 15, 2015 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 14, 2015 MEDIFIRST SOLUTIONS, INC. |
|
| April 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 333-178825 Medifirst Solutions, |
|
| April 1, 2015 |
Medifirst Solutions FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended December 31, 2014 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on |
|
| November 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MED |
|
| November 17, 2014 |
MFST / Medifirst Solutions Inc. NT 10-Q - - MEDIFIRST SOLUIONS, INC. FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended September 30, 2014 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| November 6, 2014 |
Asset Purchase Agreement, dated October 31, 2014, between Dr. Park Avenue Inc. and Dr. Park Ave.(2) EXHIBIT 10.1 ASSET PURCHASE AGREEMENT BY AND AMONG Dr. Park Avenue Inc. a Nevada corporation and Dr. Park Ave. a Nevada corporation October 31, 2014 TABLE OF CONTENTS 1. Definitions 3 2. Purchase and Sale of Assets 4 (a) Purchase and Sale of Assets 4 (b) Purchase Price 4 (d) The Closing 4 (e) Deliveries at the Closing 4 3. Representations and Warranties of Company 5 (a) Organization of Company 5 ( |
|
| November 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 31, 2014 MEDIFIRST SOLUTIONS, INC. |
|
| August 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIRS |
|
| August 15, 2014 |
MFST / Medifirst Solutions Inc. NT 10-Q - - NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ☐ Form 11-K ☒ Form 10-Q ¨ Form 10-D ☐ Form N-SAR ¨ Form N-CSR For Period Ended June 30, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on For |
|
| June 26, 2014 |
MEDIFIRST SOLUTIONS, INC. TO ACQUIRE LASER TECHNOLOGY COMPANY CEO provides company update. Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS, INC. TO ACQUIRE LASER TECHNOLOGY COMPANY CEO provides company update. Freehold, NJ — June 24, 2014 — MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to take this opportunity to update shareholders on exciting new company |
|
| June 26, 2014 |
AGREEMENT AND PLAN OF REORGANIZATION Exhibit 10.1 AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (“Agreement”) is dated as of June 24, 2014, and is by and among Medifirst Solutions, Inc., a Nevada corporation (“Medifirst”); Medical Lasers Manufacturer Inc, a Florida corporation (“MLM”) and Ronald Rubin, D.M.D. (“Rubin”) R E C I T A L S WHEREAS, MLM has developed the Time Machine Laser Program that is i |
|
| June 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 24, 2014 MEDIFIRST SOLUTIONS, INC. |
|
| May 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIR |
|
| May 16, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [x] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| May 9, 2014 |
EXHIBIT 99.1 FOR IMMEDIATE RELEASE Contact: Investor Relations Phone: (732) 786-8044 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE TO SHAREHOLDERS CEO provides updates regarding recent events. Freehold, NJ – May 7, 2014 – MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to take this opportunity to update shareholders and discuss |
|
| May 9, 2014 |
FINANCIAL AND CORPORATE DEVELOPMENT CONSULTING AGREEMENT EXHIBIT 10.1 FINANCIAL AND CORPORATE DEVELOPMENT CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") is made and entered into effective as of February 10, 2014 ("Effective Date") by and between MEDIFIRST SOLUTIONS, INC,, a Nevada corporation (the "Company"); and NATIVE HOLDINGS, LLC, a Delaware limited liability company (the "Consultant"); the Company and the Consultant being hereinafter collect |
|
| May 9, 2014 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 10, 2014 MEDIFIRST SOLUTIONS, INC. |
|
| April 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 333-178825 Medifirst Solutions, |
|
| April 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X ] Form 10-K [] Form 20-F [] Form 11-K [] Form 10-Q [] Form 10-D [] Form N-SAR [] Form N-CSR For Period Ended: December 31, 2013 [] Transition Report on Form 10-K [] Transition Report on Form 20-F [] Transition Report on Form 11-K [] Transition Report on Form 10-Q [] Trans |
|
| February 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 13, 2014 MEDIFIRST SOLUTIONS, INC. |
|
| February 21, 2014 |
AGREEMENT AND PLAN OF REORGANIZATION Exhibit 10.1 AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (“Agreement”) is dated as of February 13, 2014, and is by and among Medifirst Solutions, Inc., a Nevada corporation (“Medifirst”) and Consumer Resources Consultants, Inc., a Florida corporation (“Consumer”). R E C I T A L S WHEREAS, Medifirst desires to acquire 1,200 shares of the common stock of Consumer ( |
|
| February 19, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2014 MEDIFIRST SOLUTIONS, INC. |
|
| February 19, 2014 |
AGREEMENT AND PLAN OF REORGANIZATION EX-10.1 2 f8k021314ex10imedifirst.htm AGREEMENT AND PLAN OF REORGANIZATION Exhibit 10.1 AGREEMENT AND PLAN OF REORGANIZATION THIS AGREEMENT AND PLAN OF REORGANIZATION (“Agreement”) is dated as of February 13, 2014, and is by and among Medifirst Solutions, Inc., a Nevada corporation (“Medifirst”) and Consumer Resources Consultants, Inc., a Florida corporation (“Consumer”). R E C I T A L S WHEREAS, |
|
| November 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MED |
|
| November 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| August 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIRS |
|
| August 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Fo |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIR |
|
| May 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-1178825 CUSIP NUMBER 58471B103 (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 3 |
|
| May 2, 2013 |
Exclusivity and Non-circumvention Agreement EXHIBIT 10.1 Exclusivity and Non-circumvention Agreement May /1/ 2013 THIS AGREEMENT is entered into by and between BRUCE SCHOENGOOD, for MEDIFIRST SOLUTIONS, a Nevada Corporation, whose principal place of business is located at 3171 U.S. 9, Suite 292, Old Bridge, NJ 08857 (hereinafter jointly referred to as "MEDIFIRST") and Panacea Photonics Corporation located at 30030 Scenic Byway Road, Henders |
|
| May 2, 2013 |
MEDIFIRST SOLUTIONS, INC. ANNOUNCES NEW FOR IMMEDIATE RELEASE EXHIBIT 99.1 Contact: Investor Relations Phone: (561) 558-6872 Email: [email protected] Website: www.medifirstsolutions.com MEDIFIRST SOLUTIONS, INC. ANNOUNCES NEW HEALTHCARE AND WELLNESS DIVISION Company launches Medi-First Light Therapy Systems to exclusively market and distribute innovative Light Therapy Systems and a unique product line. Boca Raton, Fl – May 2, |
|
| May 2, 2013 |
Entry into a Material Definitive Agreement - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2013 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 333-178825 23-3888260 State or other jurisdiction Commission IRS Employer of incorporation File Number Identification No. |
|
| April 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 333-178825 Medifirst Solutions, |
|
| March 19, 2013 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Phone: Email: Website: Investor Relations (732) 786-8044 [email protected] www.medifirstsolutions.com MEDIFIRST SOLUTIONS, INC. ANNOUNCES LICENSE AGREEMENT Company Enters Deal to Create Products for Both Healthcare Professionals and Caretakers of Mentally Ill, Special Needs and Spectrum Children Boca Raton, Fl – March 19, 2013 – MEDIFIRST SOLUT |
|
| March 19, 2013 |
Exhibit 10.1 LICENSE AGREEMENT This Agreement is effective as of March 19, 2013 between King Media, Inc., a New Jersey corporation (“Licensor”) and Medifirst Solutions, Inc., a Nevada corporation (“Licensee”). Recitals WHEREAS, Licensor is the creator of “Successful Child Magazine” and the holder of all tradenames, trademarks and other intellectual property associated with said magazine as describ |
|
| March 19, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2013 MEDIFIRST SOLUTIONS, INC (Exact name of registrant as specified in its charter) Nevada 333-178825 23-3888260 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No. |
|
| November 9, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MED |
|
| September 5, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A-1 Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-178825 MEDIFIRST SOL |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: MEDIFIRST SOLUTIONS |
|
| June 29, 2012 |
424B2 1 f424b2medifirst.htm PROSPECTUS Filed Pursuant to Rule 424(b)(2) File No. 333-178825 PROSPECTUS MEDIFIRST SOLUTIONS, INC. 8,521,750 Shares of Common Stock Price $0.10 Currently No Public Market Exists for Our Common Stock This Prospectus relates to periodic offers and sales of 2,000,000 shares of the Company’s Common Stock for future issuance in connection with possible acquisition transact |
|
| June 26, 2012 |
MEDIFIRST SOLUTIONS, INC. 4400 N. Federal Hwy, Boca Raton Florida 33431 Tel: 561-558-6872 Fax: 561-293-2700 June 26, 2012 Max A. Webb Assistant Director Division of Corporation Finance Securities and Exchange Commission Washington, D.C. 20549 Medifirst Solutions, Inc. Registration Statement on Form S-1 Filed On March 29, 2012 File No. 333-178825 Dear Mr. Webb: Pursuant to Rule 461 under the Securi |
|
| June 15, 2012 |
Medifirst Solutions, Inc. 4400 N. Federal Hwy Suite 54 Boca Raton FL 33431 June 15, 2012 Max A. Webb Assistant Director Division of Corporation Finance Securities and Exchange Commission Washington, D.C. 20549 Medifirst Solutions, Inc. Amendment No.7 to Registration Statement on Form S-1 Filed On March 29, 2012 File No. 333-178825 Dear Mr. Webb: Enclosed is the referenced Amendment No. 7 which inc |
|
| June 15, 2012 |
BYLAWS MEDIFIRST SOLUTIONS, INC. A Nevada Profit Corporation ARTICLE I 1. Annual Meeting Exhibit 3.3 BYLAWS OF MEDIFIRST SOLUTIONS, INC. A Nevada Profit Corporation ARTICLE I SHAREHOLDERS 1. Annual Meeting A meeting of the shareholders shall be held annually for the election of directors and the transaction of other business on such date in each year as may be determined by the Board of Directors, but in no event later than 100 days after the anniversary of the date of incorporation o |
|
| June 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AMENDMENT NO. 7 MEDIFIRST SOLUTIONS, INC. (Name of small business issuer in its charter) NEVADA 2721 27-3888260 (State or other jurisdiction of organization) (Primary Standard Industrial Classification Code) (Tax Identification Number) 4400 North Federal Highway |
|
| June 15, 2012 |
EX-3.1 2 fs12012a7ex3imedifirst.htm ARTICLES OF INCORPORATION FILED ON NOVEMBER 8, 2010 Exhibit 3.1 CORPORATE CHARTER I, ROSS MILLER, the duly elected and qualified Nevada Secretary of State, do hereby certify that MEDIFIRST SOLUTIONS, INC., did on November 5, 2010, file in this office the original Articles of Incorporation; that said Articles of Incorporation are now on file and of record in the |
|
| June 15, 2012 |
Certificate of Amendment (PURSUANT TO NRS 78.380) Exhibit 3.2 ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4020 (775) 684-5708 Website: www.nvsos.gov Certificate of Amendment (PURSUANT TO NRS 78.380) USE BLACK INK ONLY – DO NOT HIGHLIGHT ABOVE SPACE FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporation (Pursuant to NRS 78.380 - Before Issuance of Stock) |
|
| June 15, 2012 |
Exhibit 4.1 |
|
| June 13, 2012 |
June 13, 2012 Bruce Schoengood Chief Executive Officer Medifirst Solutions, Inc. 4400 North Federal Highway Suite 54 Boca Raton, Florida 33431 Re: Medifirst Solutions, Inc. Amendment No. 6 to Registration Statement on Form S-1 Filed on June 8, 2012 File No. 333-178825 Dear Mr. Schoengood: We have reviewed your responses to the comments in our letter dated May 11, 2012 and have the following additi |
|
| June 8, 2012 |
Medifirst Solutions, Inc. 4400 N. Federal Hwy Suite 54 Boca Raton FL 33431 June 8, 2012 Max A. Webb Assistant Director Division of Corporation Finance Securities and Exchange Commission Washington, D.C. 20549 Medifirst Solutions, Inc. Amendment No.6 to Registration Statement on Form S-1 Filed On March 29, 2012 File No. 333-178825 Dear Mr. Webb: Enclosed is the referenced Amendment No. 6 which now |
|
| June 8, 2012 |
BYLAWS MEDIFIRST SOLUTIONS, INC. A Nevada Profit Corporation ARTICLE I 1. Annual Meeting Exhibit 3.3 BYLAWS OF MEDIFIRST SOLUTIONS, INC. A Nevada Profit Corporation ARTICLE I SHAREHOLDERS 1. Annual Meeting A meeting of the shareholders shall be held annually for the election of directors and the transaction of other business on such date in each year as may be determined by the Board of Directors, but in no event later than 100 days after the anniversary of the date of incorporation o |
